Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2013; 19(29): 4638-4650
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4638
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4638
Table 1 Intrinsic composition of preservation solutions in this review
| UW | HTK | Celsior | IGL-1 | UW-gluconate | Kreb-Henseleit | MEM | ||
| Electrolyte | Na | 25 | 15 | 100 | 125 | 125 | 143 | 143.4 |
| (mmol/L) | K | 120 | 9 | 15 | 30 | 25 | 5.9 | 5.4 |
| Mg | 5 | 4 | 13 | 5 | 5 | 1.2 | 0.8 | |
| Ca | 0.0015 | 0.25 | 0.5 | 1.25 | 1.4 | |||
| Cl | 20 | 32 | 42 | 1 | 125.2 | 124 | ||
| SO4 | 5 | 5 | 1.2 | 0.8 | ||||
| Buffer | Phosphate | 25 | 25 | 15 | 1.2 | 1 | ||
| (mmol/L) | Bicarbonate | 25 | 25 | 26.2 | ||||
| HEPES | 10 | 20 | ||||||
| Histidine | 198 | 30 | 0.27 | |||||
| Antioxidant | Glutathione | 3 | 3 | 3 | 3 | |||
| (mmol/L) | Allopurinol | 1 | 1 | 1 | ||||
| Mannitol | 38 | 60 | ||||||
| NAC | 5 | |||||||
| Vit C | 0.25 | |||||||
| Glucose | 10 | 5 | 5.5 | |||||
| Metabolic Substrates | Adenosine | 5 | 5 | 5 | ||||
| (mmol/L) | Adenine | 5 | ||||||
| Ribose | 5 | |||||||
| Tryptophan | 2 | |||||||
| Ketoglutarate | 1 | |||||||
| Glutamate | 20 | |||||||
| Amino acid | 0.7 | |||||||
| Impermeants | Lactobionate | 100 | 80 | 100 | ||||
| (mmol/L) | Gluconate | 95 | ||||||
| Raffinose | 30 | 30 | 30 | |||||
| Colloid | HES | 50 | ||||||
| (g/L) | PEG | 1 | 50 | |||||
| Other intrinsic compounds | Insulin | 100 U | ||||||
| Dexamethason | 8 mg | |||||||
| Penicillin | 40 U | |||||||
| Phenol-red (mmol/L) | 0.03 | |||||||
| Osmolarity | 340 | 300 | 363 | 330 | 360 | 320 | 310 | |
Table 2 Overview of the clinical and experimental strategies in this review
| Clinically applied | Experimentally applied | |
| Donors | Dietary | Pharmacological |
| Pharmacological | Heat shock | |
| Ischemic (except remote ischemic) | ||
| Anesthetic | ||
| Liver grafts | SCS preservation | |
| New solution | ||
| Pharmacological additives | ||
| Additional oxygen (VSOP) | ||
| MP preservation | ||
| MP solely | ||
| MP + pharmacological additives | ||
| Flushing | ||
| Pharmacological additives |
Table 3 Animal models of hepatic steatosis for liver transplantation
| Disease | Approaches | Description | Animals | Treatment time |
| NAFLD | Genetic | Cerebral leptin receptor deficiency | Rodent | |
| Dietary | High fat | Rodent | 7 d | |
| High cholesterol | Rodent, rabbits | 8-12 wk | ||
| Cafeteria diet | Rodent | 4-15 wk | ||
| Choline/methionine-deficient | Rodent | 7 d-6 wk | ||
| High starch and fat free after fasting | Rodent | 4 d | ||
| High fat and choline deficiency | Dog | 8-12 wk | ||
| High fat and high cholesterol, plus choline deficiency or not | Miniature pig | 24 wk | ||
| High fat and carbohydrate with streptozotocin for a diabetic state | Landrace pig | 5 wk | ||
| AFLD | Dietary | Ethanol in liquid diet, intragastric infusion or gavage | Rodent | 20 h-9 wk |
| Ethanol and high fat diet | Rodent | 6 wk | ||
| Ethanol and deficient folate diet | Micropig | 12 wk |
- Citation: Liu Q, Izamis ML, Xu H, Berendsen T, Yarmush M, Uygun K. Strategies to rescue steatotic livers before transplantation in clinical and experimental studies. World J Gastroenterol 2013; 19(29): 4638-4650
- URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i29.4638
